Trial Details
COMPLETEDBasic Information
| Clinical ID | c2381 |
|---|---|
| Identifier | NCT03573908 |
| Trial Title | A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome Characterized by Constipation |
| Interventions | DRUG: Linaclotide|DRUG: Placebo |
Participant Information
| Sponsor | Ironwood Pharmaceuticals, Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-06-20 |
|---|---|
| Primary Completion Date | 2019-03-13 |
| Completion Date | 2019-04-10 |